APA

Hillen M. R., Hartgring S. A. Y., Willis C. R., Radstake T. R. D. J., Hack C. E., Lafeber F. P. J. G. & van Roon J. A. G. (20160406). The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade. : PloS one.

Chicago

Hillen Maarten R, Hartgring Sarita A Y, Willis Cynthia R, Radstake Timothy R D J, Hack Cornelis E, Lafeber Floris P J G and van Roon Joel A G. 20160406. The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade. : PloS one.

Harvard

Hillen M. R., Hartgring S. A. Y., Willis C. R., Radstake T. R. D. J., Hack C. E., Lafeber F. P. J. G. and van Roon J. A. G. (20160406). The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade. : PloS one.

MLA

Hillen Maarten R, Hartgring Sarita A Y, Willis Cynthia R, Radstake Timothy R D J, Hack Cornelis E, Lafeber Floris P J G and van Roon Joel A G. The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade. : PloS one. 20160406.